Starten Sie Ihre Suche...


Wir weisen darauf hin, dass wir technisch notwendige Cookies verwenden. Weitere Informationen

Klinik und Poliklinik für Kinder- und Jugendmedizin

Klinikum / Johannes Gutenberg-Universität Mainz

Publikationen
Ergebnisse pro Seite:  10

Kerbl, Reinhold; Berner, Reinhard; Hansen, Gesine et al.

Current Articles relevant to general Pediatrics

MONATSSCHRIFT KINDERHEILKUNDE. Bd. 171. H. 4. 2023 S. 293-294



Goebel, Sebastian; Wingerter, Arthur; Prochaska, Juergen H. et al.

Development and Phenotype of Heart Failure in Long-Term Survivors of Childhood Cancer: The CVSS Study

JOURNAL OF THE AMERICAN HEART ASSOCIATION. Bd. 12. H. 19. 2023


Zeyn, Y.; Svensson, M.; Limeres, M. et al.

Discovering nucleic acid-based adjuvants for parallel stimulation of dendritic cells and liver nonparenchymal cells

EUROPEAN JOURNAL OF IMMUNOLOGY. Bd. 53. 2023 S. 36-36


Morell, Guillem Pintos; Kampmann, Christoph; Botha, Jaco et al.

Early initiation of agalsidase alfa treatment improves clinical outcomes in male patients with classical Fabry disease: A Fabry Outcome Survey (FOS) analysis

MOLECULAR GENETICS AND METABOLISM. Bd. 138. H. 2. 2023 S. 105-105


Ewert, Annika; Rehberg, Mirko; Schlingmann, Karl Peter et al.

Effects of Burosumab Treatment on Mineral Metabolism in Children and Adolescents With X-linked Hypophosphatemia

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM. Bd. 108. H. 10. 2023 S. E998-E1006


Mora, Jaume; Chan, Godfrey Chi Fung; Morgenstern, Daniel et al.

EFFICACY AND SAFETY OF NAXITAMAB IN PATIENT SUBGROUPS WITH HIGH-RISK NEUROBLASTOMA

PEDIATRIC BLOOD & CANCER. Bd. 70. 2023


Mora, Jaume; Chan, Godfrey Chi Fung; Morgenstern, Daniel et al.

EFFICACY OF NAXITMAB IN REFRACTORY HIGH-RISK NEUROBLASTOMA

PEDIATRIC BLOOD & CANCER. Bd. 70. 2023



Lehmberg, Kai; Ledig, Svea; Wustrau, Katharina et al.

ETOPOSIDE FOR PRIMARY HLH - BETTER THAN ITS REPUTATION

PEDIATRIC BLOOD & CANCER. Bd. 70. 2023 S. S28-S29